Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells

BACKGROUND AND AIMS: The safety and efficacy of mesenchymal stem cells (MSCs) in the treatment of acute-on-chronic liver failure (ACLF) have been validated. However, the impact of the pathological ACLF microenvironment on MSCs is less well understood. This study was designed to explore the changes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yongyuan, Zhu, Shu, Zheng, Xingrong, Xu, Wenxiong, Li, Xuejun, Li, Jianguo, Gao, Zhiliang, Xie, Chan, Peng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369013/
https://www.ncbi.nlm.nih.gov/pubmed/34447679
http://dx.doi.org/10.14218/JCTH.2021.00014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369013/
https://www.ncbi.nlm.nih.gov/pubmed/34447679
http://dx.doi.org/10.14218/JCTH.2021.00014

Ejemplares similares